Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis
Authors:
- Nieves Vélez de MendizábalNMNieves Vélez de Mendizábal
- Jorge CarneiroJCJorge Carneiro
- Ricard V SoléRSRicard V Solé
- Joaquín GoñiJGJoaquín Goñi
- Jean BragardJBJean Bragard
- Ivan Martinez-ForeroIMIvan Martinez-Forero
- Sara Martinez-PasamarSMSara Martinez-Pasamar
- Jorge SepulcreJSJorge Sepulcre
- Javier TorrealdeaJTJavier Torrealdea
- Francesca BagnatoFBFrancesca Bagnato
- Jordi Garcia-OjalvoJGJordi Garcia-Ojalvo
- Pablo VillosladaPVPablo Villoslada
Open Access
- 15 July 2011
- journal article
- research article
- Published by Springer Nature in BMC Systems Biology
- Vol. 5 (1) , 114
Abstract
Background: The relapsing-remitting dynamics is a hallmark of autoimmune diseases such as Multiple Sclerosis (MS). Although current understanding of both cellular and molecular mechanisms involved in the pathogenesis of autoimmune diseases is significant, how their activity generates this prototypical dynamics is not understood yet. In order to gain insight about the mechanisms that drive these relapsing-remitting dynamics, we developed a computational model using such biological knowledge. We hypothesized that the relapsing dynamics in autoimmunity can arise through the failure in the mechanisms controlling cross-regulation between regulatory and effector T cells with the interplay of stochastic events (e.g. failure in central tolerance, activation by pathogens) that are able to trigger the immune system.Results: The model represents five concepts: central tolerance (T-cell generation by the thymus), T-cell activation, T-cell memory, cross-regulation (negative feedback) between regulatory and effector T-cells and tissue damage. We enriched the model with reversible and irreversible tissue damage, which aims to provide a comprehensible link between autoimmune activity and clinical relapses and active lesions in the magnetic resonances studies in patients with Multiple Sclerosis. Our analysis shows that the weakness in this negative feedback between effector and regulatory T-cells, allows the immune system to generate the characteristic relapsing-remitting dynamics of autoimmune diseases, without the need of additional environmental triggers. The simulations show that the timing at which relapses appear is highly unpredictable. We also introduced targeted perturbations into the model that mimicked immunotherapies that modulate effector and regulatory populations. The effects of such therapies happened to be highly dependent on the timing and/or dose, and on the underlying dynamic of the immune system.Conclusion: The relapsing dynamic in MS derives from the emergent properties of the immune system operating in a pathological state, a fact that has implications for predicting disease course and developing new therapies for MS.Keywords
This publication has 63 references indexed in Scilit:
- A protective function for interleukin 17A in T cell–mediated intestinal inflammationNature Immunology, 2009
- Multiple sclerosisThe Lancet, 2008
- Coordination of Early Protective Immunity to Viral Infection by Regulatory T CellsScience, 2008
- A Network Analysis of the Human T-Cell Activation Gene Network Identifies Jagged1 as a Therapeutic Target for Autoimmune DiseasesPLOS ONE, 2007
- IPEX as a Result of Mutations in FOXP3Journal of Immunology Research, 2007
- A robustness-based approach to systems-oriented drug designNature Reviews Drug Discovery, 2007
- Regulatory T cell adjustment of quorum growth thresholds and the control of local immune responsesJournal of Theoretical Biology, 2006
- Natural regulatory T cells in infectious diseaseNature Immunology, 2005
- The Art of the Probable: System Control in the Adaptive Immune SystemScience, 2001
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992